Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
Clinical trial NCT01651000 · COMPLETED
Trial details
- NCT number
- NCT01651000
- Sponsor
- OPKO IP Holdings II, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.